Ministry Of Health And Family Welfare

Ministry Of Health And Family Welfare has published Supply Of Quadrivalent/Trivalent Seasonal Influenza Vaccine (Siv) For Haj Session 2026 Tender For Supply Of Quadrivalent/Trivalent Seasonal Influenza Vaccine (Siv) For Haj Session 2026 , Seasonal Influenza Vaccine(Quadrivalent) (For Adults) Specification: As Per The Who Recommendations The Quadrivalent Vaccines For Use In The 2026 Influenza Season (Nh) Contain The Following: Egg-Based Vaccines • An A/Victoria/4897/2022 (H1n1)Pdm09-Like Virus; • An A/Thailand/8/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And • Ab/Phuket/3073/2013 (B/Yamagata Lineage)-Like Virus Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine(Quadrivalent) (For Adults) Specification: As Per The Who Recommendations The Quadrivalent Vaccines For Use In The 2026 Influenza Season (Nh) Contain The Following: Egg-Based Vaccines • An A/Victoria/4897/2022 (H1n1)Pdm09-Like Virus; • An A/Thailand/8/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And • Ab/Phuket/3073/2013 (B/Yamagata Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine(Quadrivalent) (For Adults) Specification: As Per The Who Recommendations The Quadrivalent Vaccines For Use In The 2026 Influenza Season (Nh) Contain The Following: Egg-Based Vaccines • An A/Victoria/4897/2022 (H1n1)Pdm09-Like Virus; • An A/Thailand/8/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And • Ab/Phuket/3073/2013 (B/Yamagata Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine(Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2026 Influenza Season (Nh) Contain The Following: Egg-Based Vaccines • An A/Victoria/4897/2022 (H1n1)Pdm09-Like Virus; • An A/Thailand/8/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine(Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2026 Influenza Season (Nh) Contain The Following: Egg-Based Vaccines • An A/Victoria/4897/2022 (H1n1)Pdm09-Like Virus; • An A/Thailand/8/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine(Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2026 Influenza Season (Nh) Contain The Following: Egg-Based Vaccines • An A/Victoria/4897/2022 (H1n1)Pdm09-Like Virus; • An A/Thailand/8/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine(Quadrivalent) (For Adults) Specification: As Per The Who Recommendations The Quadrivalent Vaccines For Use In The 2026 Influenza Season (Nh) Contain The Following: Cell- Or Recombinant-Based Vaccines • An A/Wisconsin/67/2022 (H1n1)Pdm09-Like Virus; • An A/Massachusetts/18/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And • A B/Phuket/3073/2013 (B/Yamagata Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine(Quadrivalent) (For Adults) Specification: As Per The Who Recommendations The Quadrivalent Vaccines For Use In The 2026 Influenza Season (Nh) Contain The Following: Cell- Or Recombinant-Based Vaccines • An A/Wisconsin/67/2022 (H1n1)Pdm09-Like Virus; • An A/Massachusetts/18/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And • A B/Phuket/3073/2013 (B/Yamagata Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine(Quadrivalent) (For Adults) Specification: As Per The Who Recommendations The Quadrivalent Vaccines For Use In The 2026 Influenza Season (Nh) Contain The Following: Cell- Or Recombinant-Based Vaccines • An A/Wisconsin/67/2022 (H1n1)Pdm09-Like Virus; • An A/Massachusetts/18/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And • A B/Phuket/3073/2013 (B/Yamagata Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine(Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2026 Influenza Season (Nh) Contain The Following: Cell- Or Recombinant-Based Vaccines • An A/Wisconsin/67/2022 (H1n1)Pdm09-Like Virus; • An A/Massachusetts/18/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine(Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2026 Influenza Season (Nh) Contain The Following: Cell- Or Recombinant-Based Vaccines • An A/Wisconsin/67/2022 (H1n1)Pdm09-Like Virus; • An A/Massachusetts/18/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine(Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2026 Influenza Season (Nh) Contain The Following: Cell- Or Recombinant-Based Vaccines • An A/Wisconsin/67/2022 (H1n1)Pdm09-Like Virus; • An A/Massachusetts/18/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months. Last date of submission for this tender is 2025-12-12. This is a Vaccines tender in Delhi, Delhi